PR error claimed as company merger story denied:
This article was originally published in Clinica
International Biotech, a Canadian HIV home test kit manufacturer, was briefly linked with Lignex, a waste paper conversion company,last week. Last Wednesday, a press release claimed that Toronto-based Lignex and Edmonton,Alberta-based International Biotech had signed an agreement for Lignex to acquire control. However, within hours this was denied. According to Lignex, a public relations company mistakenly put out a release without authorisation. Neither company would comment whether the deal would now go ahead.
You may also be interested in...
A collaboration between Novo and Fauna will look at animal hibernation and genetic sequencing for hints toward novel therapies for obesity. Pfizer will use Insilico’s machine learning technology in target validation.
The introduction of gene therapies has been the highest-profile new modality to reach the market, but new RNA-based therapeutics hold significant potential and could be more accessible for patients. Scrip reviews the leading drug developers in this space.